mRNA Expression Profile of SFKs and Involvement of SFKs in the Regulation of LPS-Induced Erk1/2 Signaling in PBMCs of Active BD Patients

Irtegun-Kandemir S., İÇEN TAŞKIN I., BOZKURT M., Kalkanli-Tas S.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, vol.19, no.6, pp.809-817, 2019 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 19 Issue: 6
  • Publication Date: 2019
  • Doi Number: 10.2174/1871530319666190119101756
  • Journal Name: ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.809-817

Abstract

Background: Behcet's Disease (BD) is a multisystemic inflammatory disorder affecting large vessels, lungs joints, gastrointestinal and neurological systems. The pathogenesis of BD remains poorly understood. Identifying the key signaling pathway is crucial for a complete understanding of the pathogenesis of BD.